Pfizer Inc.

A $60 million settlement has been reached and is pending approval in the class action lawsuit filed in regards to the company's sale of Warner-Lambert's diabetes drug, Rezulin. The suit was filed on behalf of purchasers of Rezulin who reside in Illinois. (Jul-02-04) [PRESS RELEASE]

Legal Help

If you have a similar problem and would like to be contacted by a lawyer at no obligation, please fill in our form on the right to submit your complaint.

Add Your Comment on This Issue

Please read our comment guidelines before posting.

Note: Your name will be published with your comment.

Your email will only be used if a response is needed.

Request Legal Help